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ABSTRACT 
Background: The human microbiota is the collection of microorganisms that is 
mostly settled in the gastrointestinal tract, predominantly bacteria. This plays a 
main role in the maintenance of the hosts’ health and may be involved in 
mechanisms for disease development. Exposure to different conditions in early life 
contributes to distinct “pioneer” bacterial communities, which shape the newborn 
infants development and influence their later physiological, immunological and 
neurological homeostasis. Newborn infants with congenital malformations of the 
gastrointestinal tract (CMGIT), necrotizing enterocolitis (NEC), and spontaneous 
intestinal perforation (SIP) commonly require abdominal surgery and enterostomy. 
While intestinal microbiota has been extensively studied in infants with 
anatomically uninterrupted intestine, the knowledge of longitudinal intestinal 
colonization in this population is scarce. 
Methods: This is an exploratory, observational, and longitudinal prospective 
study, whose primary aim is to determine longitudinally the microbiota colonization 
of the proximal remnant intestine, in newborn infants with enterostomy during the 
first three weeks after surgery by CMGIT, NEC and SIP. The secondary objective 
is to explore associations between the colonization and the variables: mode of 
delivery, gestational age, postnatal age, duration of fasting, type of enteric feeding, 
antimicrobial therapy, H2-receptor antagonist therapy and length of proximal 
remnant intestine. 
Ethics and legal issues: The study protocol was approved by the Administration 
Board and Ethics Committee of Centro Hospitalar de Lisboa Central. 
Keywords: Congenital malformations of the gastrointestinal tract, Enterostomy, 
Microbiota, Necrotizing Enterocolitis, Newborn Infants. 
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RESUMO 
Estado de arte: O microbiota humano é o conjunto de microrganismos que reside 
maioritariamente no trato gastrointestinal, e que são predominantemente 
bactérias. Desempenha um papel determinante na saúde do indivíduo e também 
pode estar envolvido no desenvolvimento de diversas patologias.  A exposição a 
condições distintas no período peri-natal contribui para o estabelecimento de um 
microbiota diferente, que influenciam o desenvolvimento dos recém-nascidos e a 
sua homeostasia à posteriori. Os recém-nascidos com malformação congénita do 
trato gastrointestinal (MCTG), com enterocolite necrosante (ECN) e perfuração 
intestinal isolada (PII) normalmente são sujeitos a cirurgia abdominal e 
enterostomia. Apesar do microbiota intestinal estar amplamente estudado em 
recém-nascidos com intestino íntegro, o conhecimento longitudinal da colonização 
intestinal nesta população é escasso. 
Métodos: Este estudo exploratório observacional prospetivo, tem como principal 
objetivo determinar o padrão de microbiota que coloniza o intestino proximal 
remanescente, em recém-nascidos com enterostomia durante as três semanas 
após a intervenção cirúrgica por MCTG, ECN e PII. O objetivo secundário 
consiste na averiguação de associações entre o tipo de colonização e as 
seguintes variáveis: tipo de parto, idade de gestação, idade pós-natal, duração da 
pausa alimentar, tipo de nutrição entérica, terapêutica antimicrobiana, 
medicamentação com antagonistas dos recetores H2 e a extensão do intestino 
proximal remanescente. 
Questões ético-legais: Este estudo foi aprovado pelo Conselho de 
Administração e Comissão de Ética do Centro Hospitalar de Lisboa Central. 
iii 
Palavras-chave: Enterocolite necrosante, Enterostomia, Malformação congénita 
do trato gastrointestinal Microbiota, Recém-nascido. 
 
iv 
v 
Index  
ABSTRACT ......................................................................................................... i 
RESUMO ............................................................................................................. ii 
INTRODUCTION ................................................................................................ 1 
AIMS................................................................................................................... 4 
METHODS ......................................................................................................... 5 
Study design ....................................................................................................... 5 
Ethical and legal issues ...................................................................................... 5 
Eligibility, inclusion and exclusion criteria ........................................................... 5 
Samples size estimation ..................................................................................... 6 
Study procedures ................................................................................................ 6 
Clinical variables ............................................................................................. 6 
Enterostomy effluent sampling and storage .................................................... 7 
Procedures for enterostomy management ...................................................... 7 
Microbiota analyzes - DNA extraction ............................................................. 8 
Microbiota analyzes - Quantitative analysis by PCR ....................................... 8 
Outcomes ........................................................................................................... 9 
Primary outcomes ........................................................................................... 9 
Secondary outcomes..................................................................................... 10 
Rationale for outcomes ..................................................................................... 10 
Primary outcome assessment ........................................................................... 13 
DISCUSSION AND CONCLUSION .................................................................. 14 
REFERENCES ................................................................................................. 16 
vi 
 
1 
 
INTRODUCTION 
The human microbiota is the collection of microorganisms that live in the human 
body, mostly settled in the gastrointestinal tract (GIT), predominantly bacteria with 
higher density in the colon(1-4). This represents an intestinal symbiosis that plays a 
principal role in the maintenance of the host’s health(5).  The microbiota may be 
involved in mechanisms for disease development and is increasingly regarded as 
an “invisible organ”(6). Microbiota participate, among others functions, in 
metabolism and nutrient digestion, vitamin synthesis, immune tolerance, intestinal 
mucosa’s maturation, and brain development(7). Exposure to different conditions in 
early life contributes to distinct “pioneer” bacterial communities, which shape the 
newborn infants development(8) and influence their later physiological, 
immunological and neurological homeostasis(9-14). 
The microbiota acquisition starts in utero and it the intestinal colonization process 
is dynamic developing rapidly from birth(6, 15, 16). At this moment, human intestine is 
an aerobic environment, which gradually becomes anaerobic over a period of 
days(8, 9). Facultative aerobes bacteria are the earliest to colonize the intestine, 
comprising Escherichia and Enterococcus, that will consume the oxygen which 
permits colonization by obligate anaerobes, including Firmicutes such as 
Clostridia, Bacteroidetes, and especially Bifidobacterium(8, 9).  
In newborn infants, the type and diversity of intestinal microbiota differs widely 
among individuals and is influenced by several factors, such as the mode of 
delivery, gestational age, infant’s postnatal age, and type of feeding; in neonates 
under intensive  care, fasting, exposure to antibiotics, H2-receptor antagonists, and 
surrounding environment are additional factors(5, 6, 17-19).    
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Interactions of host-microbiome in early life provide a signal for immune system 
development, and can influence the development of several organs(9, 20, 21); at 
intestinal level, these interactions are important for development of barrier 
function, integrity, and mucosal and systemic immune function(19). 
Under physiological conditions, the evolution of the infants’ microbiome depends 
on the initial exposure to microbes in amniotic fluid, colonization through the 
vaginal canal, feeding own mother’s milk, and skin-to-skin contact with the 
mother(22).  
In the neonatal intensive care unit (NICU), infants are usually nursed in high-
sanitary incubators, treated with antibiotics, with possible restricted own mothers’ 
milk intake and limited contact with mother’s skin(23). This is determinant for an 
early life dysbiosis, characterized by a delayed and suboptimal colonization, which 
has been associated with long-term morbidities, including obesity, inflammatory 
bowel disease, autism, asthma, and celiac disease(5, 15). Preterm infants in 
particular are immunologically immature, turning them particularly sensitive and 
responsive towards intestinal colonizing bacteria(23). In this population, the type of 
intestinal microbiota may influence the development life-threatening morbidities, 
including late onset sepsis and necrotizing enterocolitis (NEC)(19).  
Newborn infants with congenital malformations of the gastrointestinal tract 
(CMGIT), NEC, and spontaneous intestinal perforation (SIP) commonly require 
abdominal surgery and enterostomy(24). While intestinal microbiota has been 
extensively studied in infants with anatomically uninterrupted intestine(25), to the 
best of our knowledge only five longitudinal studies or case reports addressing 
intestinal colonization in infants with enterostomy were published(24, 26-29) (Table 1). 
The effect of an enteral oil supplementation on the intestinal microbiome was 
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tested in 32 preterm infants with enterostomy after surgery for CMGIT, NEC and 
SIP; the control group receiving standard nutritional therapy had relative 
expansion of many genera from Enterobacteriaceae family, including Escherichia, 
Pantoea, Serratia, and Citrobacter(24). In a case report of two preterm infants with 
enterostomy after surgery for SIP and NEC, the composition of microbiota was 
examined according to the length of remnant intestine (colostomy or 
jejunostomy)(28). In two other reported cases with ileostomy, respectively of a 
preterm infant treated for SIP and a term infant with intestinal obstruction of 
complicated cystic fibrosis, two known probiotic bacteria, Lactobacillus and 
Bifidobacterium, were found(29). In a report of four cases(26), early probiotic therapy 
was evaluated after major surgery in newborn infants, two of them with CMGIT 
and enterostomy; probiotic therapy induced the equilibrium of intestinal microbiota 
and consequently the intestinal absorptive functions were activated and severe 
infections were prevented. In an observational study(27), on 15 infants undergoing 
intestinal resection before 180 days of age (7 of them with enterostomy), due to 
CMGIT, NEC and SIP, early differences in the microbiota detected in intra-
operative intestinal tissue versus fecal samples was determined; the results 
addressed the reliance on fecal microbiota as a predictor factor for the developing 
intestinal microbiota. 
It is not known to what extent the surgical interruption affects the developing 
intestinal ecosystem in newborn infants with an enterostomy with consequent 
contact with air(29). An enterostomy represents a “window” for collection of intestine 
contents and facilitates the study of microbiota; this method was previously 
reported as an convenient method for studying the proximal intestinal microbiota, 
in adults(30). 
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Table 1. Longitudinal studies and case reports addressing colonization of proximal 
remnant intestine in infants with enterostomy. 
 
Underlying 
surgical 
condition 
Type of 
study 
Aim n Reference 
CMGIT, NEC 
and SIP 
Trial 
 
Effect of an enteral oil 
supplementation on the intestinal 
microbiome 
32 preterm 
infants 
Younge N, et 
al. 2016(24) 
SIP and NEC Case 
report 
Microbiota diversity according to 
the length of remnant intestine 
2 preterm 
infants 
Barrett E, et al. 
2013(28) 
CMGIT and 
SIP 
Case 
report 
Determination of Lactobacillus 
and Bifidobacterium probiotic 
strains in the neonatal ileum 
2 (1preterm 
and 1 term 
infant) 
Wall R, et al. 
2008 (29)  
CMGIT 
Case 
report 
Effect of early probiotic therapy 
after surgery 
2 (1preterm 
and 1 term 
infant) 
Kanamori, et 
al. 2013 (26)  
CMGIT, NEC 
and SIP Observatio
nal study 
Early differences in microbiota 
detected in intra-operative 
intestinal tissue versus fecal 
samples 
7 with 
enterostomy  
Romano-
Keeler J, et al. 
2014 (27) 
CMGIT - congenital malformation of the gastrointestinal tract; NEC - necrotizing enterocolitis; SIP - 
spontaneous intestinal perforation 
 
AIMS  
The primary aim is to determine longitudinally the microbiota colonization of the 
proximal remnant intestine, in newborn infants with enterostomy undergoing 
surgery for CMGIT, NEC and SIP. 
The secondary objective is to explore associations between the colonization and 
the following variables: mode of delivery, gestational age, postnatal age, duration 
of fasting, type of enteric feeding, antimicrobial therapy, H2-receptor antagonist 
therapy and length of proximal remnant intestine.   
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METHODS 
Study design 
This is an exploratory, observational, and longitudinal prospective study. The 
infants will be recruited at the Neonatal Intensive Care Unit of Hospital Dona 
Estefânia, Centro Hospitalar de Lisboa Central (Lisbon, Portugal), and the 
laboratory analyses will be performed at the Laboratory of Nutrition and 
Metabolism of NOVA Medical School | Faculdade de Ciências Médicas, 
Universidade NOVA de Lisboa, (Lisbon, Portugal).  
Ethical and legal issues 
The study protocol was approved by the Administration Board and Ethics 
Committee of Centro Hospitalar de Lisboa Central; major further amendments to 
the approved protocol shall be submitted for approval. Signed written informed 
consent is required from parents or legal guardians of the participants, to permit 
the collection of metadata from the medical records and the enterostomies 
effluents. Withdrawal of consent, in case parents or legal guardians decide to 
abandon the study, is contemplated without affecting the quality of care. Parents 
and legal guardians have access to the additional information provided by the 
study.   
 
Eligibility, inclusion and exclusion criteria 
Eligibility criteria: newborn infants with enterostomy after surgery for CMGIT, NEC 
or SIP.  
Inclusion criteria: consecutive newborn infants assessed up to three weeks after 
surgery.  
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Exclusion criteria: newborn infants with diagnosed inborn errors of metabolism and 
those whose parents or legal guardians will not consent to participate or withdrawn 
the consent will not be included or will be excluded a posteriori. 
Samples size estimation 
The sample size estimation was based on the prevalence of 11 patients with 
enterosostomy hospitalized during one year (January 2016 to January 2017) in the 
NICU of Hospital Dona Estefânia: 8 with NEC and 3 with CMGT. Therefore, in the 
total study period is estimated to include about 20 neonates. 
Study procedures  
Clinical variables 
Perinatal data: gestational age, antibiotics use during pregnancy and intrapartum, 
date of birth, mode of delivery (vaginal or caesarean section), sex, weight, length, 
and head circumference at birth; 
Surgical data: underlying surgical condition (CMGIT, NEC and SIP), date of 
surgery, level of enterostomy (duodenostomy, jejunostomy, ileostomy, or 
colostomy), length of proximal remnant intestine (if available), type of feeding 
before surgery; 
Postsurgical data: daily record of body weight , enteral feeding (including the 
fasting period), parenteral nutrition, type feeding (trophic or nutritional feeding), 
type of feds (mother’s milk, donor’s milk, or  formula), mode of administration 
(intermittent or continuous), volume administered, central catheter and type, 
antimicrobial and H2-receptor antagonists therapy, invasive ventilation, and acute 
events such as sepsis; enterostomy effluent characteristics, including consistency 
(watery, with granules or pasty), amount, and color; and date of discharge. 
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Figure 1. Timeline of the study 
Enterostomy effluent sampling and storage 
The samples will be collected by a nurse and delivered to the investigator. The 
collection will be done using a sterile syringe directly from the ostomy bag to a 
sterile collection tube. The previously coded tube will be stored at 4 °C for a 
maximum of 24-hours period in a thermal bag with a thermoregulator. 
Subsequently, the tubes will be stored at the Laboratory of Nutrition and 
Metabolism, conserved at -80 °C prior to the samples analysis. All samples will be 
anonymised and labelled by study number.  
The first sample will be collected as close as possible to the surgical procedure, 
after the placement of the ostomy bag. From that day, a new collection will be 
done every 3 days, until the 21st day after the surgical intervention (Figure 1). If 
the onset of enteral nutrition is greatly delayed, the time limit may be increased.    
  
Procedures for enterostomy management   
In the NICU of Hospital Dona Estefânia, only staff and direct family or legal 
guardians have contact with newborn infants, and they are taught on adequate 
hygienic and aseptic procedures.  
By routine the ostomy bag is changed every 3 days, and every day the content is 
aspirated every 3 hours. Attempting to assure a sufficient amount of sample for 
analysis, the previously scheduled aspiration to the collection will be suspended. 
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Microbiota analyzes - DNA extraction 
DNA will be extracted directly from intestinal content samples using a NZY Tissue 
gDNA Isolation Kit, as previously described by Marques et al(31), with some 
modifications adapted from a protocol described by Zoetendal et al (32). The 
principal modifications encompass the utilization of 5-10 g of intestinal content, 
and before performing pre-lysis with 1.4 ml of buffer NT1, samples will be mixed 
with 5 ml of PSB, vortexing during 30 seconds and centrifuged at 3000 x g for 1 
min. After these steps, the mixture will be incubated, in the water bath with shaking 
at 80°C for 15 min. Samples will be centrifuged at 3000 x g for 1 min. Then, 25 μL 
of proteinase K were added to the supernatant for incubation at 70°C for 15 min. 
The following steps are the manufacturer’s instructions, but the quantity of ethanol 
added is based in the proportion 210 μL of ethanol to 200 μL of final supernatant, 
and must repeat the step of passing 600 μL of the mixture through the column of 2 
ml NZYSpin Tissue about 15-20 times or until there is no mixture left. DNA 
quantification will be assessed with a NanoDrop spectrophotometer (Thermo 
Scientific, Wilmington, DE, USA). 
Microbiota analyzes - Quantitative analysis by PCR 
Real-time PCR will be performed as described by Marques et al(31). PCR reactions 
mixtures (total of 10 mL) contain 5 μL of 2xFaststart SYBR Green (Roche 
Diagnostics Ltd), 0.2 μL of each primer (final concentration of 0.2 μM), 3.6 μL of 
water and 1 μL of DNA (equilibrated to 20 ng). Previously published primers will be 
used for the identification of microorganisms and the conditions for PCR 
amplification reactions are reported in Table 2. The analysis of data will be done 
by using the LightCycler software (Roche Applied Science).  
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AT- Anneling Temperature (ºC) 
Table 2. Primer sequences and real-time PCR conditions used for microbiota analysis 
 
Target group Primer sequence (5’-3’) Genomic DNA Standard AT Reference 
Actinobacteria 
F: TACGGCCGCAAGGCTA 
R: TCRTCCCCACCTTCCTCCG 
Bifidobacterium longum 
subsp. Infantis 
ATCC 15697 
61.5 (33) 
Bifidobacterium 
F:CGC GTC YGG TGT GAA AG  
R: CCC CAC ATC CAG CAT CCA 
Bifidobacterium longum 
subsp. Infantis 
ATCC 15697 
60 (31) 
Firmicutes 
F:ATG TGG TTT AAT TCG AAG CA  
R:AGC TGA CGA CAA CCA TGC AC 
Lactobacillus gasseri  
ATCC 33323 
60 (31) 
Lactobacillus 
F: GAG GCA GCA GTA GGG AAT CTT C  
R:GGC CAG TTA CTA CCT CTA TCC TTC TTC 
Lactobacillus gasseri  
ATCC 33323 
60 (31) 
Staphylococcus 
F: GAT GTG CGA AAG CGT GGG GAT 
R: GAA CTG AGA ACA ACT TTA TGG GA 
S. aureus 
ATCC 12600 
 
60 (34) 
S. aureus 
F: AAT CTT TGT CGG TAC ACG ATA TTC TTC ACG 
R: CGT AAT GAG ATT TCA GTA GAT AAT ACA ACA 
S. aureus 
ATCC 12600 
 
56 (35) 
S. epidermis 
F: ATC AAA AAG TTG GCG AAC CTT TTC A 
R: CAA AAG AGC GTG GAG AAA AGT ATC A 
S. epidermidis 
ATCC 14990 
 
56 (35) 
Clostridium 
F: AAAGGAAGATTAATACCGCATAA 
R: ATCTTGCGACCGTACTCCCC 
C. perfringens 
AF316589 
54 (36) 
Enterococcus 
F: CCC TTA TTG TTA GTT GCC ATC ATT  
R: ACT CGT TGT ACT TCC CT TGT 
Enterococcus gilvus 
 ATCC BAA-350 
61 (31) 
B. fragilis 
F: TCRGGAAGAAAGCTTGCT 
R: CATCCTTTACCGGAATCCT 
B. fragilis 
ATCC 25285 
60 (37) 
Protobacteria 
F: TCGTCAGCTCGTGTYGTGA 
R: CGTAAGGGCCATGATG 
E. coli 
ATCC 25922 
61.5 (33) 
E. coli 
F: GTTAATACCTTTGCTCATTGA 
R:ACCAGGGTATCTAATCCTGTT 
E. coli 
ATCC 25922 
60 (38) 
K. pneumoniae 
F: CCTGGATCTGACCCTGCAGTA 
R: CCGTCGCCGTTCTGTTTC 
K. pneumoniae 
ATCC 13883 
60 (37) 
Serratia 
F: CCGGCATCGGCAAAGTCT 
R: ATCTGGCCCGGCTCGTAGCC 
Serratia ficaria 
ATCC 33105 
 
 
55 (39) 
Candida 
F: TTGGTGGAGTGAT TTGTCTGCT 
R:TCTAAGGGCATCACAGACCT G 
C. albians 
ATCC10231 
60 (40) 
 
 
Outcomes 
Primary outcomes 
To describe longitudinally the postsurgical microbiota colonization of the proximal 
remnant intestine, specifically in each underlying condition (CMGIT, NEC or SIP).  
10 
Secondary outcomes 
To determine associations of types of microorganism identified with mode of 
delivery, gestational age, postnatal age, duration of fasting, type of enteric feeding, 
antimicrobial therapy, H2-receptor antagonist therapy and length of proximal 
remnant intestine. 
Rationale for outcomes  
The NICU environment has major influence for  intestinal dysbiosis and 
pathogenic colonization(9), with short- and long-term negative consequences for 
health(10, 11). The intestinal bacteria acquired by newborn infants under intensive 
care have been found to be the same that appear on the hospital surfaces and 
equipment(22). The intestinal microbiota becomes more similar among inpatient 
newborn infants as the duration of hospitalization increases(10, 41).  
The importance of this study is grounded in some unexplored aspects. Infants with 
enterostomy have specific factors that may influence the development of intestinal 
microbiota, including the interruption of the intestine and the intraluminal contact 
with air through the stoma(42, 43). Pathogenic bacteria that can be identified may 
contribute to understand their possible role in neonatal intensive care related-
infection and thus be useful to plan preventive and therapeutic approaches. 
Enterostomy is a convenient window to collect samples and an opportunity to 
study the microbiota of the remnant intestine(28). The knowledge on longitudinal 
intestinal colonization in newborn infants with enterostomy, including by potentially 
pathogenic microorganisms, is scarce (Table 1)(24, 26-29). 
The mechanisms underlying the surgical conditions of infants with enterostomy are 
quite diverse. For instance, intestinal inflammation and ischemia are present in 
NEC and SIP(44, 45), but not in CMGIT. These factors are likely to influence the 
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microbiota existent previously to surgery and in the postoperative period. Despite 
a single microbial “cause” for NEC is not evident, a decrease in Firmicutes and an 
increase in Proteobacteria phyla were described prior to diagnosis(5, 19). In 
addition, a low diversity of bacteria and of potential pathogenic microorganisms 
such as Clostridium spp., E. coli, Klebsiella pneumoniae, torovirus, astrovirus, 
cytomegalovirus, and Candidia spp. were described in NEC(23, 46).   
Several general factors are likely to influence intestinal microbiota in newborn 
infants under intensive care (mode of delivery, gestational age, postnatal age, 
enteric feeding, antimicrobial therapy) and particular factors in newborn infants 
with enterosmomy (H2-receptor antagonists, length of remnant intestine). The 
associations of these factors with the type of intestinal colonization have not been 
sufficiently studied in this last group and the rationale to evaluate those 
associations is described below. 
- Mode of delivery: while vaginally delivered infants are colonized with 
Lactobacillus and Prevotella species, in infants born by cesarean section the 
microbiota is dominated  by species such Clostridium, Staphylococcus, 
Propionobacterium, and Corynebacterium, and characterized by deficiency of 
anaerobes like Bacteroides and Bifidobacterium(6, 47, 48). 
- Gestational age and postnatal age: prematurity affects microbiota composition, 
which is different between preterm and full-term infants(11, 21). Preterm infants 
have a low diversity, with a delayed Bifidobacterium microbiota colonization, a 
high prevalence of Enterobacteriaceae, Staphylococcus, Enterococcaceae and 
other lactic acid bacteria as the genus Lactobacillus and Weissella(21). In addition, 
preterm neonates have a greater number of pathogenic bacteria, such as 
Escherichia coli and Clostridium difficile(14). 
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- Fasting and type of enteric nutrition: feeding is one of the most important 
modulator of microbiota diversity and the first postnatal external component in 
contact with the neonatal intestinal tract(23, 48, 49). In the early postoperative period 
the neonates may have variable periods of fasting; thereafter, the neonate diet 
can vary according to the condition and evolution, including  own mother milk, 
donor milk, fortified human milk, or formula(5). Breastfeeding induces intestinal 
enrichment in Bifidobacterium spp., Lactobacillus and Bacteroides. In contrast, 
formula-fed neonates have an abundance of Clostridia and Staphylococci(48), and 
higher proportion of proinflammatory Gammaproteobacteria which delay 
intestinal maturation(50). 
- Antimicrobial therapy: antibiotic treatment, used for pathogenic bacteria, also 
affects non-pathogenic bacteria(22). Perinatal exposure to antibiotics, even 
prenatal, is an independent risk factor for NEC occurrence(22, 48), with 
consequences for later health(9, 11). Infants, whose mothers have received  
antibiotics during labor, have decreased Bifidobacterium after birth and reduced 
Bacteroides at 3 months, changes that may persist until the first year of age(51). 
Postnatal antibiotic treatment reduces Bifidobacterium spp., Lactobacillus and 
Clostridia and overgrowth of Enterococcus spp., Staphylococcus and 
Enterobacteriaceae compared with untreated(11, 22, 48, 51, 52), and diversity of 
microbiota have an inverse correlation with the duration of antibiotics 
treatment(52).   
- H2-receptor antagonist therapy: physiologically, human stomach produce acid 
decreasing the passage of  viable pathogens into the distal intestine(53). In some 
intestinal resections in neonates, H2-receptor antagonists are used to reduce the 
effect of gastrin hyper-secretion(54). Therapeutically inhibited gastric acid 
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production influence the microbiota(5, 55). The use of H2-receptor antagonists in 
preterm infants is associated with increased phylum Proteobacteria, which 
contains Enterobacteriaceae(41). 
- Length of proximal remnant intestine: number and composition of microbes 
varies along the GIT(29); and its concentration increases with proximity of the 
colon due to its relatively high pH and low peristaltism in comparison with the 
upper GIT(4). To the best of our knowledge, only one study evaluated the 
microbiota composition according to the length of remnant intestine in newborn 
infants with enterostomy(28); in infants with colostomy, there was a predominance 
of phyla Actinobacteria and Firmicutes, and Bifidobacterium and Clostridium at 
genus level(28); in infants with ileostomy, there was a predominance of the phylum 
Proteobacteria, and Bifidobacterium. This last genera was initially dominant and 
decreased over the time, with an increase in Streptococcus and 
Enterobacteriaceae(28).   
Primary outcome assessment 
The microorganisms colonizing the proximal remnant intestine will be identified  
and quantified by using a precise technique culture-independent, real-time PCR 
analytical method that targets the bacterial 16S(56) and fungi 18S ribosomal RNA 
gene(57). This is particularly sensitive, given its greater hybridization potential for 
primers on conserved regions, which target regions close to hypervariable 
regions(58). In addition, it permits a quick analysis and it is not a very expensive 
technique. This method, based on the microorganisms DNA identification, has 
advantages providing information on viable and not-viable microorganisms. 
Therefore, it allows the quantification of microorganisms that become not-available 
with the contact with oxygen through the ostomy and during its stay within the 
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ostomy bag. Specifics primers allow precise quantification of each known species, 
and the use of SYBR Green permits the real-time monitoring of amplification of a 
targeted DNA molecule during the PCR.   
The primers selected are representative of the principal phyla for a first general 
characterization. These selected primers are also specific for bacteria and fungi 
most commonly colonizing the intestine of newborn infants, as well as potentially 
pathogenic microorganisms identified in newborn infants cared in NICU. 
The microbiota is collected longitudinally from the enterostomy’s effluent samples. 
The periodicity of every 3 day change of ostomy bags determines the same 
periodicity for sample collection. The collection will be made within the first day 
after of the bag change, to minimize the bias of potential contamination by growth 
of microorganisms that may remain in the bag after aspiration.  
The period scheduled for the study is 21 days after enterostomy is based on the 
average of stay of 16 days reported for newborn infants with corrective surgery of 
major CMGIT(59). This period is much shorter than the reported stay of preterm 
infants with NEC needing surgery(60).  
DISCUSSION AND CONCLUSION 
While general factors affecting the microbiota in preterm and full-term newborn 
infants have been widely addressed in several studies(5, 6, 17-19), specific factors 
involved in particular conditions have less explored. It is still unclear which type of 
colonization occurs in newborn infants with enterostomy cared for in intensive care 
unit, influenced by specific factors such as postoperative fasting, exposure to 
antibiotics, H2-receptor antagonists, length of remnant intestine, and contact with 
air through the ostomy. The knowledge about longitudinal intestinal colonization in 
in this population is scarce(24, 26-29). 
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This observational study is likely to have the following interests in infants with 
enterostomy: 1) to determine the pattern of colonization in three underlying 
conditions: CMGIT, NEC or SIP; 2) to identify pathogenic microorganisms with 
potential role in nosocomial infections, contributing to plan preventive and 
therapeutic measures. 
Strength of this study should be acknowledged. This is the first longitudinal 
colonization assessment of the proximal remnant intestine in three distinct surgical 
conditions, during the first three weeks after enterostomy; this assessment is 
based on a sensitive technique to identify viable and not viable cells.   
The limitations of our study should also be acknowledged. Firstly, in this single 
centre study, it may difficult to achieve a sufficient sample size to test certain 
outcomes - some aforementioned associations. Secondly, the contact with air 
through the ostomy may affect the colonization by anaerobe bacteria. Thirdly, in 
case the collection will not be made within the first day after of the bag change, the 
potential proliferation of bacteria in ostomy bag may be a bias. Fourthly, the 
bacterial identification will not be made by the more refined whole-genome 
analysis techniques, since non-availability of required specialist bioinformatics and 
other logistic support. 
This exploratory study is promising for future research in the studied population, as 
it may serve as basis for interventional studies evaluating the effect of modulation 
(eg, prebiotics and probiotics) of the intestinal microbiota on short and long-term 
health. 
To the best of our knowledge, this is the first protocol for a longitudinal study 
assessing the intestinal colonization in newborn infants with enterostomy. 
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